5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[[4-(methanesulfonamido)phenyl]methyl]-2-oxo-1H-pyridine-3-carboxamide | 1429297-23-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[[4-(methanesulfonamido)phenyl]methyl]-2-oxo-1H-pyridine-3-carboxamide
• CAS: 1429297-23-3
• 化学式: C₂₂H₂₀Cl₂FN₃O₅S
• 分子量: 528.388
• InChiKey: RCVQSGXTXRDEBO-GFCCVEGCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  34
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  122
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  methyl 5-hydroxy-2-methoxypyridinecarboxylate 在 三甲基氯硅烷 、 偶氮二甲酸二异丙酯 、 水 、 N,N-二异丙基乙胺 、 三苯基膦 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 sodium iodide 、 lithium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 、 甲苯 、 乙腈 为溶剂， 生成 5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[[4-(methanesulfonamido)phenyl]methyl]-2-oxo-1H-pyridine-3-carboxamide
  参考文献：
  名称：

  Novel 5-(benzyloxy)pyridin-2(1H)-one derivatives as potent c-Met inhibitors

  摘要：

  A series of novel 5-(benzyloxy)pyridin-2(1H)-ones were designed, synthesized and biologically evaluated for c-Met inhibition. Various amides and benzoimidazoles at C-3 position were investigated. A potent compound 12b with a c-Met IC50 of 12 nM was identified. This compound exhibited potent inhibition of EBC-1 cell associated with c-Met constitutive activation and showed high selectivity for c-Met than other tested 11 kinases. The binding model 12b with c-Met was disclosed by docking analysis. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.02.037

文献信息

• Novel 5-(benzyloxy)pyridin-2(1H)-one derivatives as potent c-Met inhibitors
  作者：Dengyou Zhang、Jing Ai、Zhongjie Liang、Wei Zhu、Xia Peng、Xianjie Chen、YinChun Ji、Hualiang Jiang、Cheng Luo、Meiyu Geng、Hong Liu

  DOI：10.1016/j.bmcl.2013.02.037

  日期：2013.4

  A series of novel 5-(benzyloxy)pyridin-2(1H)-ones were designed, synthesized and biologically evaluated for c-Met inhibition. Various amides and benzoimidazoles at C-3 position were investigated. A potent compound 12b with a c-Met IC50 of 12 nM was identified. This compound exhibited potent inhibition of EBC-1 cell associated with c-Met constitutive activation and showed high selectivity for c-Met than other tested 11 kinases. The binding model 12b with c-Met was disclosed by docking analysis. (C) 2013 Elsevier Ltd. All rights reserved.